Clinical Study of CD7 CAR-T Cells for Relapsed/refractory Autoimmune Diseases

NCT06871644 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria

Interventions

BIOLOGICAL: T cell injection targeting CD7 chimeric antigen receptor

Sponsor

PersonGen BioTherapeutics (Suzhou) Co., Ltd.